Samuel Wallis

Head of Case Processing
Bristol Myers Squibb
Samuel Wallis is Head of Case Processing at Bristol Myers Squibb, based in London, responsible for pharmacovigilance operations across one of the industry’s highest ICSR volumes. He has led major transformation programs spanning global safety operations, including the migration of BMS’s global safety database to the cloud and the deployment of AI-enabled case processing.

Articles by Samuel Wallis

  • The Next Test for AI in Pharmacovigilance Is Trust, Not Accuracy

    Monday, September 21, 2026
    An AI model can be right and still not be trusted. That’s what Bristol Myers Squibb (BMS) found six months into rolling out AI-powered adverse event processing: while F1 performance scores were tracking upward, the audit trail found reviewers still ...
  • <<
  • >>